From Data to Digital Twins: ThinkBio.Ai® Participates in Cleveland Clinic’s AI Summit 2025
California, USA – July 11, 2025 — ThinkBio.Ai®, a leading innovator in AI-powered healthcare and life sciences solutions, successfully participated in the Cleveland Clinic’s AI Summit 2025, held on July 11, 2025, at the InterContinental Hotel, Cleveland, Ohio.
The summit brought together healthcare leaders, researchers, and technology pioneers to explore the rapidly evolving role of artificial intelligence in transforming clinical care and patient outcomes.
Representing ThinkBio.Ai®, Dr. Apurva Kalia delivered a featured talk during the Summit’s Breakfast Meeting titled Advancing Clinical Healthcare Through Patient-Digital Twins.
“The session explored how multimodal clinical data, from lab results and imaging to genomics and drug response, can be transformed into dynamic digital twins to support predictive modeling, personalize treatments, and optimize clinical trials.
AI has the power to reimagine how we understand and treat patients,” said Dr. Kalia. “By creating intelligent digital twins, we can navigate complex clinical data more effectively and support clinicians with data-driven insights at every step.”
Pradeep Palazhi, CEO of ThinkBio.Ai®, added, “Our support for the AI Summit reflects our mission to translate scientific complexity into practical tools for clinicians and researchers. We believe AI should not only accelerate discovery but also make precision care scalable, ethical, and clinically actionable. That’s the future we’re building at ThinkBio.Ai®.”
ThinkBio.Ai’s presence at the summit underscores its continued commitment to building domain-driven AI platforms that bridge the gap between research, diagnostics, and care delivery. The company’s ecosystem of tools is designed to enhance real-time decision support, accelerate clinical trials, and enable personalized, scalable healthcare innovation.
About ThinkBio.Ai®
ThinkBio.Ai® is a pioneering digital biology, AI, and healthcare-focused company dedicated to advancing healthcare through innovative digital tools and solutions. By merging bioscience and digital biology with next-generation AI technologies, ThinkBio.Ai®strives to create impactful biotech and healthcare innovations accessible to a global audience. The company is based in California and is privately funded. ThinkBio.Ai®currently has biotech, life sciences, and healthcare customers in the US, UK, and India and is involved in many research projects in the areas of Proteomics, Metabolomics, Biological Target Identification, Healthcare Foundation Models, Responsible AI, Spatial Biology, Transcriptomics, Clinical Decision Support, and Pathways and Precision Medicine.